Articles related to SURVIVORSHIP

In a French retrospective cohort, infants with Ewing sarcoma had favorable long-term survival after age-adjusted chemotherapy and predominantly surgical local control, although the 17-patient sample limits conclusions about treatment intensity and late toxicity.

Early detection remains one of the strongest tools against prostate cancer, with localized disease associated with nearly 100% 5-year survival. An oncology nursing review highlights screening, risk stratification, precision medicine, and the expanding role of nurses in education, care coordination, and survivorship support.

Growing numbers of cancer survivors are prompting renewed discussion about how survivorship services should be delivered, with oncology and palliative care leaders emphasizing symptom management, quality of life, clinician training, and long-term support needs.

Reevaluation of major hormone therapy studies has prompted renewed discussion about menopause treatment in breast cancer survivors. Emerging interpretation of older trial data suggests treatment risks may vary by patient characteristics and hormone formulation rather than applying uniformly across all populations.

A case of chemotherapy-induced menopause left unmanaged for six years prompted a physician’s pointed critique of survivorship care failures, highlighting the clinical and legal stakes of untreated premature ovarian insufficiency following gonadotoxic therapy.

“The extended-hours model was effective… early morning dose, in-center observation, overnight remote monitoring equipment, and next-day follow-up cut the need for extended shifts and differential pay.”